News FDA’s Critical Role in Ensuring Safe and Effective Flu Vaccines December 4, 2024 Read More » FDA Approves Emrosi™ for the Treatment of Rosacea November 4, 2024 Read More » ORLYNVAH October 25, 2024 Read More » VYLOY™ October 18, 2024 Read More » VYALEV October 17, 2024 Read More » C&A Naturistics Issues Voluntary Nationwide Recall of AK Forte Tablets con Ortiga yOmega 3 Due to the Presence of Undeclared Drug Ingredients October 16, 2024 Read More » Staska Pharmaceuticals, Inc. Issues Recall of Ascorbic Acid Solution for Injection (Preservative Free, Non-Corn) 500mg/mL Due to the Presence of Glass Particles October 16, 2024 Read More » IMULDOSA INJECTION October 14, 2024 Read More » HYMPAVZI October 11, 2024 Read More » Page1 Page2 Page3 … Page41 Benefit Advisors & Employees - Want to know more? Members: Please call the number on the back of your ID card or e-mail member.services@benecardpbf.com Clients: Contact your Client Relations Manager Full Name(Required)Email(Required) Comment(Required)Company Name(Required)CAPTCHA
C&A Naturistics Issues Voluntary Nationwide Recall of AK Forte Tablets con Ortiga yOmega 3 Due to the Presence of Undeclared Drug Ingredients October 16, 2024 Read More »
Staska Pharmaceuticals, Inc. Issues Recall of Ascorbic Acid Solution for Injection (Preservative Free, Non-Corn) 500mg/mL Due to the Presence of Glass Particles October 16, 2024 Read More »